MedTrace Logo

Gaze Contingent Feedback for Anxiety Disorders in Children

NCT03171363 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2018-09-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of anxiety disorders in children.

Conditions

  • Anxiety Disorders

Interventions

BEHAVIORAL

Gaze-contingent feedback

Participants will receive gaze-contingent feedback according to their viewing patterns

Sponsors & Collaborators

  • Tel Aviv University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2018-04-01
Completion
2018-04-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03171363 on ClinicalTrials.gov